AZP-531 (CAS No. 1088543-62-7) – GMP Manufacturer

AZP-531 (CAS No. 1088543-62-7) – GMP Manufacturer

$2.00

AZP-531 is a GMP-grade cyclic peptide (purity ? 99.79%) — an unacylated ghrelin (UAG) analog with properties that support improved glycemic control, appetite regulation, and weight stabilization. Ideal for metabolic research and Prader-Willi syndrome models. For laboratory research use only.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

AZP-531 (CAS No. 1088543-62-7), also known as Livoletide or Cyclo(des-acyl ghrelin(6-13)), is a synthetic analogue of unacylated ghrelin (UAG). It has demonstrated significant potential in metabolic regulation, including the reduction of hyperphagia, weight stabilization, and improvement of glucose metabolism. In early human trials, AZP-531 was well tolerated, showed favorable pharmacokinetics suitable for once-daily dosing, promoted modest weight loss, improved glycemic control, and reduced postprandial glucose markers without increasing insulin levels. Manufactured under GMP standards with high purity (99.79%), AZP-531 assures consistency and reliability for experimental use. Intended strictly for laboratory research.


Product Specifications

Parameter Details
Product Name AZP-531
Synonyms Livoletide; Cyclo(des-acyl ghrelin(6-13))
CAS No. 1088543-62-7
Purity ? 99.79% (GMP-grade)
Molecular Formula C??H??N??O??
Molecular Weight Approx. 962.0 g/mol
Mechanism Analogue of unacylated ghrelin (UAG), metabolic regulator
Pharmacodynamics Regulates appetite, improves glycemic control, insulin-sparing
Appearance White to off-white cyclic peptide powder
Solubility Soluble in aqueous buffers; DMSO may aid solubility for stock solutions
Storage Conditions Store at –20 °C; protect from light and moisture
Manufacturing Standard GMP-compliant
Applications Metabolic disease models, neuroscience of appetite, Prader-Willi syndrome research
Regulatory Status For laboratory research use only

Mechanism of Action & Research Applications

Mechanism of Action: AZP-531 mimics unacylated ghrelin, acting on metabolic and appetite-regulating pathways independent from acylated ghrelin’s orexigenic effect. It appears to restrict hunger, support glucose control without elevating insulin, and modulate metabolic signaling.

Research Applications:

  • Appetite & Feeding Behavior: Useful in models exploring hyperphagia, particularly in rare genetic conditions like Prader-Willi syndrome.

  • Glycemic Regulation: Supports study of insulin sensitivity and postprandial glucose dynamics.

  • Weight Management Therapeutics: Valuable in research for obesity and metabolic syndrome.

  • Pharmacokinetic Studies: Suitable as a peptide with favorable once-daily dosing characteristics.

    images-azp-531-oxidized-formula


Side Effects (Research Context Only)

AZP-531 is intended strictly for laboratory and preclinical model research. In early human studies, it was well tolerated, with no serious adverse effects reported. Observed outcomes included modest weight reduction and improved glucose parameters. No long-term safety data exists; handle with institutional laboratory standards.


Disclaimer

AZP-531 is strictly for laboratory research use only. It is not approved for clinical, diagnostic, or therapeutic purposes. Please use and store according to institutional safety protocols.

其他信息

重量 0.6 公斤
尺寸 38 × 21 × 38 厘米

评价

目前还没有评价

成为第一个“AZP-531 (CAS No. 1088543-62-7) – GMP Manufacturer” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

EMI Options

Select at least 2 products
to compare